UNICEF has airlifted over 43,000 doses of the R21/Matrix-M malaria vaccine to Bangui, Central African Republic, marking a significant stride in combatting the disease and safeguarding children’s lives. This initial…
Monkeypox, a viral disease, continues its global impact. Today, the World Health Organization (WHO) unveiled a new strategic framework aimed at guiding efforts to prevent and manage monkeypox outbreaks. The…
In the latest release of the World Health Statistics by the World Health Organization (WHO), the impact of the COVID-19 pandemic on global life expectancy and healthy life expectancy at…
Legend Biotech, a leading global cell therapy company, has announced the forthcoming presentation of new and updated data from its CARTITUDE clinical development program at the 2024 American Society of…
Eisai has announced its participation in the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (#ASCO24), held both virtually and in-person in Chicago, Illinois from May 31 to June…
UCB, a leading global biopharmaceutical company, has announced the publication of results from the Phase 3 BE HEARD I and BE HEARD II trials in The Lancet. These trials evaluated…
A global oncology company today announced the presentation of new analyses for BRUKINSA® (zanubrutinib) at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago from May 31 to…
Clinical Trials Day is globally recognized on May 20, and this year, the Walgreens Clinical Trials team celebrated with a special event dedicated to women’s health. Appropriately, May is National…
First-in-human data for the potential first-in-class anti-CEACAM5 ADC with topoisomerase 1 inhibitor payload, M9140, in the treatment of metastatic colorectal cancer to be featured in an oral presentation. Phase I…
Eli Lilly and Company announced today a significant increase in investment for its Lebanon, Indiana, manufacturing site. The company has committed an additional $5.3 billion, bringing the total investment to…
Today, Astellas announced the signing of a memorandum of understanding with YASKAWA Electric Corporation (YASKAWA), marking the beginning of discussions toward creating an innovative cell therapy ecosystem. This collaboration aims…
CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) have announced the publication of groundbreaking findings in Nature Communications, revealing the results from a comprehensive phase 1/2/3a/3b study investigating the safety,…